HOME >> BIOLOGY >> NEWS
Protective gene may enhance vaccine responses

Researchers from the University of Chicago have discovered the first of a new class of "protective factors" that appear to be required for the development of memory T cells, the cells that form the core of a vaccine response. The finding could help scientists create more effective vaccines and may lead to potent immune system-based therapies against diseases that have previously eluded vaccines, such as cancer or AIDS.

When the immune system detects an invader, such as a virus, T cells with an affinity for that particular invader multiply rapidly, attack and eliminate infected cells. Once the infection is cleared, however, 90 to 95 percent of those T cells die off, a process called contraction. The five percent or so that survive are known as memory T cells. If a similar infection recurs, these experienced warriors are prepared to rush to the site, recognize that invader and eradicate it again.

Scientists know a great deal about the rapid proliferation and differentiation of these T cells but very little about the factors that regulate contraction. In the September, 2004, issue of Nature Immunology published on-line August 15 -- the researchers show that activation of the gene for the Serine protease inhibitor 2A (Spi2A) can prevent the death of T cells during the contraction phase, resulting in about five times as many memory T cells.

"Drugs based on protective factors such as Spi2A could provide an enormous boost to vaccines," said study author Philip Ashton-Rickardt, professor of pathology and a member of the committee on immunology at the University of Chicago. "This could allow us to extend the duration of an immune response against chronic infections or to focus the power of the immune system on tumor cells, targets that have thus far been quite elusive."

The researchers began by screening approximately 11,000 genes from mouse T cells, to find the small number of genes that were more active in the T cells that survived th
'"/>

Contact: John Easton
jeaston@uchospitals.edu
773-702-6241
University of Chicago Medical Center
15-Aug-2004


Page: 1 2

Related biology news :

1. Protective mechanism exploited by tumors may provide new cancer treatment
2. Protective protein caps discovered at ends of human chromosomes
3. Experimental Staph Vaccine Broadly Protective In Animal Studies
4. Potential for enhanced sequestration of carbon in soils supports evaluations
5. Probing the surface of white blood cells to enhance immune system medicine
6. Plant gene discovery could enhance plant growth, reduce fertilizer needs and phosphate pollution
7. Technology could enhance accuracy of breast biopsy
8. Manipulating biotope space can enhance beneficial biodiversity effects
9. Taxanes may enhance immunity in breast cancer patients
10. UC Riverside researchers develop low-carb corn with enhanced protein and oil
11. Athletics, genetic enhancement and ethics

Post Your Comments:
*Name:
*Comment:
*Email:


(Date:11/12/2019)... ... November 12, 2019 , ... ... from nonprofit U.S. universities and research institutions for its Instrumentation Grant for ... up to $1.2 million per site for the acquisition of instrumentation, development and ...
(Date:11/7/2019)... (PRWEB) , ... November 07, 2019 , ... R3 Stem ... 50% off through the rest of 2019. The code to use during checkout is ... well. , R3 is the nation’s leader in regenerative therapies with over 12,000 successful ...
(Date:11/5/2019)... ... November 05, 2019 , ... Dr. Lauren Kopp ... dentistry to Seattle, WA, including porcelain veneers , smile makeovers, dental implants, ... University of Washington, Dr. Kopp is passionate about serving her Seattle community with ...
Breaking Biology News(10 mins):
(Date:11/5/2019)... ... November 05, 2019 , ... Focal Healthcare ... Mark for its Fusion Bx 2.0 prostate fusion biopsy solution. By combining information ... Bx 2.0 will give urologists across Europe the ability to perform targeted transrectal ...
(Date:11/2/2019)... ... 2019 , ... A clinical trial usually involves many different ... principal investigators, supply chain managers, manufacturers, IRT, CRAs and so on. Lack of ... data, potentially leading to patient risk. , By having a single source of ...
(Date:11/2/2019)... (PRWEB) , ... October 31, 2019 , ... ... released by pharma artificial intelligence pioneer tellic. drug360 brings tellic’s expertise in ... new tool allows researchers to quickly uncover relationships between genes, diseases, variants, phenotypes, ...
(Date:10/30/2019)... ... October 30, 2019 , ... Western University of ... innovation and technology play in educating the next generation of health care providers. ... and presentations by WesternU administrators and representatives of companies working with the University ...
Breaking Biology Technology:
Cached News: